Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Astria Therapeutics, Inc. (ATXS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/10/2023 |
SC 13G
| FMR LLC reports a 12.8% stake in ASTRIA THERAPEUTICS INC |
12/22/2022 |
SC 13G
| Deep Track Capital, LP reports a 7.3% stake in Astria Therapeutics, Inc. |
12/21/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
09/08/2022 |
SC 13G
| Vivo Opportunity, LLC reports a 7.1% stake in Astria Therapeutics, Inc. |
09/02/2022 |
SC 13G
| Cormorant Asset Management, LP reports a 5.4% stake in Astria Therapeutics, Inc. |
06/17/2021 |
SC 13G
| Fairmount Funds Management LLC reports a 5.3% stake in Catabasis Pharmaceuticals, Inc. |
06/15/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/02/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/10/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/19/2019 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 5% stake in Catabasis Pharmaceuticals, Inc. |
07/10/2018 |
SC 13G
| FEDERATED INVESTORS INC reports a 14.7% stake in CATABASIS PHARMACEUTICALS, INC. |
07/02/2018 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 5% stake in Catabasis Pharmaceuticals, Inc. |
06/28/2018 |
SC 13G
| Stonepine Capital Management, LLC reports a 6.5% stake in Catabasis Pharmaceuticals, Inc. |
06/25/2018 |
SC 13G
| Empery Asset Management, LP reports a 7% stake in Catabasis Pharmaceuticals, Inc. |
02/23/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/10/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
02/16/2016 |
SC 13G
| ADVANCED TECHNOLOGY VENTURES VII LP reports a 7.4% stake in Catabasis Pharmaceuticals, Inc. |
|
|